comparemela.com
Home
Live Updates
Ablacon - Breaking News
Pages:
Latest Breaking News On - Ablacon - Page 1 : comparemela.com
The FLOW-AF multicenter, randomized controlled trial shows Ablacon s Electrographic Flow® (EGF®) Mapping software (Ablamap®) results in improved ablation outcomes in persistent atrial fibrillation
/PRNewswire/ Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation.
United states
Duke rohlen
David haines
Ablacon ablamap
Vivek reddy
Ablacon inc
Prnewswire ablacon inc
Ajax health
Zeus health backed
Late breaking clinical trials
Scientific advisory board
Menlo park
Healthquest capital
Polaris partners
vimarsana © 2020. All Rights Reserved.